This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shapiro, R. A. Articles by Darveau, R. P. Search for Related Content PubMed PubMed Citation Articles by Shapiro, R. A. Articles by Darveau, R. P.

 Previous Article  |  Next Article 

Infect. Immun., Jan 1997, 293-297, Vol 65, No. 1
Copyright © 1997, American Society for Microbiology

Identification of CD14 residues involved in specific lipopolysaccharide recognition

RA Shapiro, MD Cunningham, K Ratcliffe, C Seachord, J Blake, J Bajorath, A Aruffo and RP Darveau
Inflammation Department, Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.

CD14 is a key molecule responsible for the innate host inflammatory response to microbial infection. It is able to bind a wide variety of microbial ligands and facilitate the activation of both myeloid and nonmyeloid cells. However, its specific contribution to the innate recognition of bacteria is not known. Presently there is no information on the contribution of individual CD14 residues to Escherichia coli lipopolysaccharide (LPS) binding or on the molecular basis of the interaction between CD14 and LPS from other bacteria. LPS obtained from Porphyromonas gingivalis, a bacterium associated with chronic inflammatory disease, binds CD14 and activates myeloid cells but does not facilitate the activation of nonmyeloid cells. The transfer and binding of these two LPS species to soluble CD14 recombinant globulin proteins with single point mutations was examined. Functional activity of the mutant proteins was monitored by E-selectin expression on human umbilical cord endothelial cells. The analysis identified a charge reversal mutation in a single residue, E47, that demonstrated selective binding to E. coli LPS but not to P. gingivalis LPS. E-selectin activation assays indicated that proteins with mutations at position E47 maintained their structural integrity. Other mutations, including a charge reversal mutation of residue E58, did not significantly reduce the binding of either LPS ligand or the ability of the molecule to facilitate E-selectin activation. These data demonstrate that CD14 can selectively recognize different LPS ligands.

This article has been cited by other articles:

• Kim, J.-I., Lee, C. J., Jin, M. S., Lee, C.-H., Paik, S.-G., Lee, H., Lee, J.-O. (2005). Crystal Structure of CD14 and Its Implications for Lipopolysaccharide Signaling. J. Biol. Chem. 280: 11347-11351 [Abstract] [Full Text]  
• Mizel, S. B., West, A. P., Hantgan, R. R. (2003). Identification of a Sequence in Human Toll-like Receptor 5 Required for the Binding of Gram-negative Flagellin. J. Biol. Chem. 278: 23624-23629 [Abstract] [Full Text]  
• Dobrovolskaia, M. A., Medvedev, A. E., Thomas, K. E., Cuesta, N., Toshchakov, V., Ren, T., Cody, M. J., Michalek, S. M., Rice, N. R., Vogel, S. N. (2003). Induction of In Vitro Reprogramming by Toll-Like Receptor (TLR)2 and TLR4 Agonists in Murine Macrophages: Effects of TLR "Homotolerance" Versus "Heterotolerance" on NF-{kappa}B Signaling Pathway Components. J. Immunol. 170: 508-519 [Abstract] [Full Text]  
• Muroi, M., Ohnishi, T., Tanamoto, K.-i. (2002). Regions of the Mouse CD14 Molecule Required for Toll-like Receptor 2- and 4-mediated Activation of NF-kappa B. J. Biol. Chem. 277: 42372-42379 [Abstract] [Full Text]  
• Darveau, R. P., Arbabi, S., Garcia, I., Bainbridge, B., Maier, R. V. (2002). Porphyromonas gingivalis Lipopolysaccharide Is Both Agonist and Antagonist for p38 Mitogen-Activated Protein Kinase Activation. Infect. Immun. 70: 1867-1873 [Abstract] [Full Text]  
• Cunningham, M. D., Shapiro, R. A., Seachord, C., Ratcliffe, K., Cassiano, L., Darveau, R. P. (2000). CD14 Employs Hydrophilic Regions to ""Capture"" Lipopolysaccharides. J. Immunol. 164: 3255-3263 [Abstract] [Full Text]  
• Viriyakosol, S., Mathison, J. C., Tobias, P. S., Kirkland, T. N. (2000). Structure-Function Analysis of CD14 as a Soluble Receptor for Lipopolysaccharide. J. Biol. Chem. 275: 3144-3149 [Abstract] [Full Text]  
• Stelter, F., Loppnow, H., Menzel, R., Grunwald, U., Bernheiden, M., Jack, R. S., Ulmer, A. J., Schutt, C. (1999). Differential Impact of Substitution of Amino Acids 9-13 and 91-101 of Human CD14 on Soluble CD14-Dependent Activation of Cells by Lipopolysaccharide. J. Immunol. 163: 6035-6044 [Abstract] [Full Text]  
• van Furth, A. M., Verhard-Seijmonsbergen, E. M., Langermans, J. A. M., van Dissel, J. T., van Furth, R. (1999). Anti-CD14 Monoclonal Antibodies Inhibit the Production of Tumor Necrosis Factor Alpha and Interleukin-10 by Human Monocytes Stimulated with Killed and Live Haemophilus influenzae or Streptococcus pneumoniae Organisms. Infect. Immun. 67: 3714-3718 [Abstract] [Full Text]  
• Lamont, R. J., Jenkinson, H. F. (1998). Life Below the Gum Line: Pathogenic Mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62: 1244-1263 [Abstract] [Full Text]  
• Yu, W., Soprana, E., Cosentino, G., Volta, M., Lichenstein, H. S., Viale, G., Vercelli, D. (1998). Soluble CD141-152 Confers Responsiveness to Both Lipoarabinomannan and Lipopolysaccharide in a Novel HL-60 Cell Bioassay. J. Immunol. 161: 4244-4251 [Abstract] [Full Text]  
• Dziarski, R., Tapping, R. I., Tobias, P. S. (1998). Binding of Bacterial Peptidoglycan to CD14. J. Biol. Chem. 273: 8680-8690 [Abstract] [Full Text]